Sol-Gel Technologies (SLGL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Sol-Gel Technologies (SLGL) is Neutral.

The composite score behind that read is -0.15, weighing +0.31 of bullish evidence against -0.46 bearish.

Sol-Gel Technologies last closed at $71.77, +2.03% on the session.

Against the IVW growth benchmark the position is +1.23% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

13 graded predictions for SLGL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Sol-Gel Technologies in the 19th percentile on return on equity, where 100 is best.

Sol-Gel Technologies is classified under Health Care / Pharmaceuticals, with a market capitalisation of $230.29M.

StockMap tracks Sol-Gel Technologies as the 91st largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Sol-Gel Technologies ranks 97th of 151 in the group, against a group median of -0.08.